Lundbeck sites
|
Contact Us
|
About Cipralex
Key publications
For your patients
Q & A
Prescribing information
You are here:
Home
»
About Cipralex
»
Efficacy
»
Efficacy in Social Anxiety Disorder (SAD)
Efficacy in Social Anxiety Disorder (SAD)
Cipralex vs. Paroxetine
After 24 weeks’ treatment, escitalopram (20 mg/day) showed superior efficacy to paroxetine (20 mg/day) in SAD.
Cipralex vs. Placebo
In SAD, Cipralex showed superior efficacy over placebo on the Liebowitz Social Anxiety Scale (LSAS).
Clinical relevance of Cipralex compared with placebo was indicated by the improvement of work and social-life items of the Sheehan disability scale.
About Cipralex
Efficacy
Efficacy in depression
Efficacy in Generalised Anxiety Disorder (GAD)
Efficacy in Social Anxiety Disorder (SAD)
Efficacy in Panic Disorder (PD)
Efficacy in Obsessive Compulsive Disorder (OCD)
Fast Onset of Action
Cipralex vs. Citalopram
Cipralex vs. Venlafaxine xr
Tolerability
Adverse events
Discontinuation symptoms
Overdose
Alcohol use
Special populations
Other aspects
How does it work?
Microdialysis data
Serotonin Dual-Action
Visualisations
Product Monograph
Literature Search
PubMed
Google Scholar
Related key publications
»
Superior efficacy within Anxiety
»
What is SAD?